Antithrombin Market by Application, Dosage Form & Forecast - 2025

Global Antithrombin Market - An Overview:

The consolidated vendor landscape of global antithrombin market witnesses intense competition and the proactive measures taken by players in this market to carve off a large share of the market growth will also take the market to a higher growth trajectory. As per Transparency Market Research, as competition intensifies, players will divert more efforts towards research and development.

Over the forecast period of 2017 to 2025, the global antithrombin market would grow at a compound annual growth rate of 5.2%. And, by the end of this forecast period, the revenue generated by the market would reach the mark of USD 704.5 million. In the year 206, the value was a mere 448.2 million.

Request Sample Of Report -  https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4500

Factors that are shaping up the way the global antithrombin market operates in the future include:

• Demand for this protein is set to increase in the market over the forecast period owing to an increase in the use of diagnostics test. It is important to note here that as the world population enters an intense geriatric phase, the demand for antithrombin would only increase as this segment of the population is susceptible to various illnesses and thus requires diagnostics.
• One in six people across the world will aged 65 and above by 2050. This means that a large number of people will need cardiac surgeries, considering diets are deterioration and lack of exercise is marking lifestyles. Antithrombin would be used as a therapeutic in these cases. This would lead to significant growth in the market over the forecast period.
• As awareness regarding rare disorders increase, the market for antithrombin would see an upward curve. One in every 3000 people in the United States of America has this deficiency.

Request For Custom Research -  https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=4500

Global Antithrombin Market: Snapshot

The global antithrombin market features a consolidated vendor landscape with the presence of a handful of established players that are scattered in regional and global markets. The market is also characterized by stiff competition with the dominance of a few players that occupy leading revenue base. With the entry of new players in this market, which has ample growth prospects, the competition is likely to heat up.

The global antithrombin market is primarily driven by the widespread use of antithrombin for the treatment of several medical conditions such as hereditary antithrombin deficiency, extracorporeal membrane oxygenation (ECMO), disseminated intravascular coagulation (DIC), and sepsis. The increasing use of antithrombin as a combination therapy with heparin is likely to open immense growth opportunities for this market.

As per a report by Transparency Market Research, the global antithrombin market is likely to clock a CAGR of 5.2% for the forecast period between 2017 and 2025. At this pace, the worldwide market for antithrombin is anticipated to attract a revenue of US4.5 mn by the end of 2025 from its worth of US8.2 mn in 2016.

Request the Coronavirus Impact Analysis across Industries and Markets -  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=4500

Therapeutics Most Attractive Application Segment

The report on the global antithrombin market has been assessed on the basis of four categories: application, source, dosage form, and geography. The key application segments of this market are therapeutics, research, and diagnostics. The therapeutics segment stood as the leading contributor holding almost 94.4% of the market in 2016. This is attributed to the therapeutic efficacy of antithrombin for several diseases, and thus have led to the availability of therapeutic antithrombin preparations with approved indication. On the other hand, research based application is gaining traction with rising initiatives of in vitro study and to discover new disease indications.

Based on source, human, goat milk, and others are the segments into which the global antithrombin market is divided in this report. The human segment served the demand to attract a revenue that constituted 88.6% of the overall market in 2016. While the goat milk segment held 7.0% of the market in 2016, the segment is expected to gain market share to account for 9.8% of the overall market by 2025. Goat milk derived antithrombin are currently available in North America and Europe. However, the availability of these products in Asia Pacific and Rest of the World is expected to boost the share of goat milk source segment during the forecast period.

About This Author

monali Joined: April 13th, 2018